Effects of thalidomide on reproductive function and early embryonic development in male and female New Zealand white rabbits.
BACKGROUND
The present work was performed to determine the effect of thalidomide exposure on reproductive function and early embryonic development.


METHODS
Twenty-five female New Zealand White rabbits were orally gavaged with 0, 10, 50, or 100 mg/kg/day thalidomide 14 days prior to mating through to gestation day 7 for a total of 22 days. Treated females were Caesarean-sectioned approximately 29 days after the date of attempted mating. Following mating with treated females, male rabbits (25/dose) were gavaged with 0, 30, 150, or 500 mg/kg/day beginning 14 days prior to mating with a group of untreated females (25/dose). Doses were administered through mating until the day before sacrifice for a minimum of 56 days. Untreated females were Caesarean-sectioned 29 days after the last attempted mating. Comprehensive necropsy and histopathology of the reproductive system were performed.


RESULTS
Treated females had reduction in body weight gain during gestation. Mating and pregnancy parameters were unaffected by thalidomide. At 100 m/kg, litter averages for corpora lutea, implantations, litter sizes, does with viable fetuses and live fetuses decreased and the number of early resorptions, does with any resorptions, does with all conceptuses resorbed, and the percent resorbed conceptuses per litter increased. The number of early resorptions, the average number of early resorptions per litter, and the percent resorbed conceptuses per litter increased at 10 and 50 mg/kg. There were no thalidomide-related external fetal malformations. Mating and fertility in male rabbits were unaffected by thalidomide. There was an increased incidence of flaccid testes at 150 and 500 mg/kg and of bilateral small testes in all treated groups. At 500 mg/kg, there was degeneration of the germinal epithelium of the testicles with an increase in multinucleated giant cells in seminiferous tubule and a loss of round and elongating spermatids.


CONCLUSIONS
Thalidomide had no adverse effects on mating and fertility in male and female rabbits dosed up to 500 and 100 mg/kg/day, respectively, for 14 days prior to mating. After 56 day of dosing, histopathologic changes with no associated sperm abnormalities were observed in the testicles. Embryonic development NOAEL for treated females mated to untreated males was <10 mg/kg. Corresponding fertility NOAEL for treated males mated to untreated females was 500 mg/kg.
Celgene Corporation, Warren, New Jersey 07059, USA. steo@celgene.com
Steve K
SK
Teo
Kevin H
KH
Denny
David I
DI
Stirling
Steve D
SD
Thomas
Sandra L
SL
Morseth
Alan M
AM
Hoberman
D037881:Aborted Fetus; D000022:Abortion, Spontaneous / Q000139:chemically induced; D000818:Animals; D001835:Body Weight / Q000187:drug effects; D002585:Cesarean Section; D005314:Embryonic and Fetal Development / Q000187:drug effects*; D005247:Feeding Behavior / Q000187:drug effects; D005260:Female; D005298:Fertility / Q000187:drug effects; D005333:Fetus / Q000187:drug effects / Q000196:embryology; D008297:Male; D015394:Molecular Structure; D009929:Organ Size / Q000187:drug effects; D011817:Rabbits; D012098:Reproduction / Q000187:drug effects*; D012726:Sexual Behavior, Animal / Q000187:drug effects; D013081:Sperm Motility / Q000187:drug effects; D013737:Testis / Q000166:cytology; D013792:Thalidomide / Q000737:chemistry / Q000633:toxicity*
D013792:Thalidomide